Meta-analysis of sex differences in gene expression in schizophrenia

Schizophrenia is a severe psychiatric disorder which influences around 1 % of the worldwide population. Differences between male and female patients with schizophrenia have been noted. There is an earlier age of onset in males compared with females with this diagnosis, and in addition, there are differences in symptom profiles between the sexes. The underlying molecular mechanism of sex difference remains unclear. Here we present a comprehensive analysis to reveal the sex differences in gene expression in schizophrenia with stringent statistics criteria. We compiled a data set consisting of 89 male controls, 90 male schizophrenia patients, 35 female controls and 32 female schizophrenia patients from six independent studies of the prefrontal cortex (PFC) in postmortem brain. When we tested for a sex by diagnosis interaction on gene expression, 23 genes were up-regulated and 23 genes were down-regulated in the male group (q-value < 0.05), several genes are related to energy metabolism, while 4 genes are located on sex chromosome. No genes were statistically significant in the female group when multiple testing correction were conducted (q-value <0.05), most likely due to the small sample size. Our protocol and results from the male group provide a starting point for identifying the underlying different mechanism between male and female schizophrenia patients.

[1]  Jianhua Zhang,et al.  The role of GABARAPL1/GEC1 in autophagic flux and mitochondrial quality control in MDA-MB-436 breast cancer cells , 2014, Autophagy.

[2]  M. Barnes,et al.  Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function , 2009, Molecular Psychiatry.

[3]  Christopher H Woelk,et al.  A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. , 2012, Journal of psychiatric research.

[4]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[5]  Brian Dean,et al.  Gene Expression Profiling in Brodmann's Area 46 from Subjects with Schizophrenia , 2007, The Australian and New Zealand journal of psychiatry.

[6]  Stephan Heckers,et al.  Definition and description of schizophrenia in the DSM-5 , 2013, Schizophrenia Research.

[7]  Daniel R. Weinberger,et al.  Gene Expression of Metabolic Enzymes and a Protease Inhibitor in the Prefrontal Cortex Are Decreased in Schizophrenia , 2004, Neurochemical Research.

[8]  Steven R. Head,et al.  Molecular profiles of schizophrenia in the CNS at different stages of illness , 2008, Brain Research.

[9]  Peter Falkai,et al.  Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. , 2010, Journal of psychiatric research.

[10]  A. Gogos,et al.  Sex differences and the role of estrogen in animal models of schizophrenia: Interaction with BDNF , 2013, Neuroscience.

[11]  Hai-Gwo Hwu,et al.  Family-based association study of SELENBP1 in schizophrenia , 2009, Schizophrenia Research.

[12]  Jayashri Kulkarni,et al.  Gender Differences in Schizophrenia and First-Episode Psychosis: A Comprehensive Literature Review , 2012, Schizophrenia research and treatment.

[13]  Á. Carracedo,et al.  The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia , 2007, Molecular Psychiatry.

[14]  N. Craddock,et al.  Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. , 2010, Archives of general psychiatry.

[15]  Rudolf Uher,et al.  Gene–Environment Interactions in Severe Mental Illness , 2014, Front. Psychiatry.

[16]  M. Frosch,et al.  Effects of gender on nigral gene expression and parkinson disease , 2007, Neurobiology of Disease.

[17]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[18]  D. Lewis,et al.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.

[19]  S. Akbarian.  Epigenetic mechanisms in schizophrenia , 2014, Dialogues in clinical neuroscience.

[20]  Sam Richman,et al.  An online database for brain disease research , 2006, BMC Genomics.

[21]  John D. Storey.  The positive false discovery rate: a Bayesian interpretation and the q-value , 2003 .

[22]  V. Haroutunian,et al.  Variations in differential gene expression patterns across multiple brain regions in schizophrenia , 2005, Schizophrenia Research.

[23]  John P A Ioannidis,et al.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.

[24]  Pablo V Gejman,et al.  Genetics of schizophrenia: new findings and challenges. , 2011, Annual review of genomics and human genetics.

[25]  Ulrich Schall,et al.  Finding the needle in the haystack: A review of microarray gene expression research into schizophrenia , 2012, The Australian and New Zealand journal of psychiatry.

[26]  E. Kemether,et al.  Thalamic transcriptome screening in three psychiatric states , 2009, Journal of Human Genetics.

[27]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[28]  P. Pavlidis,et al.  A cross-laboratory comparison of expression profiling data from normal human postmortem brain , 2010, Neuroscience.

[29]  Marquis P. Vawter,et al.  The first decade and beyond of transcriptional profiling in schizophrenia , 2012, Neurobiology of Disease.

[30]  Jesse Gillis,et al.  Genome-wide expression profiling of schizophrenia using a large combined cohort , 2011, Molecular Psychiatry.

[31]  M. Keshavan,et al.  Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients , 2005, Molecular Psychiatry.

[32]  Alan S. Brown.  The environment and susceptibility to schizophrenia , 2011, Progress in Neurobiology.

[33]  Károly Mirnics,et al.  Analyzing Schizophrenia by DNA Microarrays , 2011, Biological Psychiatry.

[34]  David A Lewis,et al.  Transcriptome alterations in the prefrontal cortex of subjects with schizophrenia who committed suicide. , 2008, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.